Get started
Author

Pati Revazishvili

Observed names: P Revazishvili, P. Revazishvili
OpenAlex ID: A5077324607
Melatonin Biosynthesis, Receptors, and the Microbiota–Tryptophan–Melatonin Axis: A Shared Dysbiosis Signature Across Cardiac Arrhythmias, Epilepsy, Malignant Proliferation, and Cognitive Trajectories
2026 · Alexandre Tavartkiladze, Russel J. Reiter, et al. · International Journal of Molecular Sciences · 2
PDF
Chronotherapy Enhances Melatonin Secretion and Liver Enzyme Activity, Improving Therapeutic Outcomes in Hodgkins Lymphoma Patients
2024 · A. Tavartkiladze, G. Simonia, et al. · Journal of Cancer Research · 2
PDF
Treatment of refractory recurrent gastrointestinal stromal tumors with adoptive cellular immunotherapy (TILs) and personalized vaccine
2019 · A.A. Tavartkiladze, R. Khutsishvili, et al. · Annals of Oncology · 2
Nocturnal Melatonin Amplitude Collapse Is Associated with Age-Independent Convergence of Microbiome and Glymphatic Biomarkers
2026 · Alexandre Tavartkiladze, Levan Tavartkiladze, et al. · Current Issues in Molecular Biology · 1
Low Melatonin and Post COVID Syndrome: Unveiling SIBO as a Potential Pre Cancerous Condition in the Post-Pandemic Era
2024 · Maia Maisuradze, Alexandre Tavartkiladze, et al. · Journal of Cancer Research · 1
PDF
Circulating Tumor Cells (CTCs), Melatonin, and uNOS: New Frontiers in Cancer Diagnosis and Treatment
2023 · A. Tavartkiladze, P. Revazishvili, et al. · The Journal of Liquid Biopsy · 1
63P The impact of disruption of melatonin secretion on the structural-functional changes of the microbiome and the role of the melatonin-microbiome axis in the initiation of carcinogenesis
2023 · A.A. Tavartkiladze, T. Potskhoraia, et al. · ESMO Open · 1
PDF
Influence of agomelatine and trastuzumab on the HER2/neu(+), MT1 (+) and MT2 (+) chemo and immunoresistant breast cancer cells lines from the previously treated patients by targeted therapy with trastuzumab.
2019 · Alexandre Tavartkiladze, Pati Revazishvili, et al. · Journal of Clinical Oncology · 1
Lower 24-hour urinary 6-sulfatoxymelatonin and exploratory bile-acid and microbiome associations in adults with dyslipidemia: a prospectively enrolled cross-sectional study
2026 · Alexandre Tavartkiladze, Levan Tavartkiladze, et al. · Annals of Medicine
PDF
Relative Melatonergic Status and Systemic Inflammatory, Oxidative, and Biological Aging Burden in Adults: An Exploratory Cross-Sectional Biomarker Analysis
2026 · Alexandre Tavartkiladze, Levan Tavartkiladze, et al. · Cancers
AminoTriComplex in Integrative Oncology: Integrated Preclinical Safety and Prospective Clinical Evidence in Metastatic Solid Tumors
2026 · Alexandre Tavartkiladze, Levan Tavartkiladze, et al. · Preprints.org
A Dysbiosis–Urolithin A Depletion–Low 6-Sulfatoxymelatonin Triad as a Composite Biomarker Framework Across Age-Related Vascular and Malignant Disease States
2026 · Alexandre Tavartkiladze, Levan Tavartkiladze, et al. · International Journal of Molecular Sciences
PDF
Subtype-specific melatonin receptor expression on circulating tumor cells and associated inflammatory/metabolic biomarkers in breast cancer: A 3-year cohort analysis (n=171).
2026 · Alexandre Tavartkiladze, Pati Revazishvili, et al. · Journal of Clinical Oncology
Stage-dependent metabolic reprogramming in treatment-naïve lung adenocarcinoma: From oxidative flexibility to glycolytic entrapment.
2026 · Alexandre Tavartkiladze, Pati Revazishvili, et al. · Journal of Clinical Oncology
Exceptional and typical biomarker responses to AminoTriComplex in metastatic prostate cancer: a case series
2026 · Alexandre Tavartkiladze, Gaiane Simonia, et al. · Journal of Medical Case Reports
176eP Neuroendocrine disruption in triple-negative Breast Cancer: Dopamine deficiency as a prognostic marker and potential therapeutic target
2026 · T. Akhvlediani, A.A. Tavartkiladze, et al. · ESMO Open
PDF
540eP Integrated multi-biomarker panel for predicting disease irreversibility in advanced triple-negative breast cancer: Glycolysis indicators, inflammatory markers, and matrix metalloproteinases
2026 · A. Petriashvili, A.A. Tavartkiladze, et al. · ESMO Open
58P Melatonin deficiency as a prognostic biomarker and therapeutic target in triple-negative breast cancer: Correlation with Epithelial-to-Mesenchymal transition and survival outcomes
2026 · A. Petriashvili, A.A. Tavartkiladze, et al. · ESMO Open
578eP Hepcidin-mediated iron dysregulation in triple-negative breast cancer: Implications for combination therapy with hepcidin inhibitors
2026 · T. Akhvlediani, A.A. Tavartkiladze, et al. · ESMO Open
PDF
Circulating and Serum Biomarkers in Non-Small Cell Lung Cancer
2026 · Revaz Turmanidze, Alexandre Tavartkiladze, et al. · International Journal of Science and Research (IJSR)
PDF
Melatonin Anchored Chrononutraceutical Strategy for Epigenetic Rejuvenation A Four-Year Multiphase Evaluation of AminoTriComplerex™
2026 · Alexandre Tavartkiladzex, Gaiane Simonia, et al. · Journal of Cancer Research
PDF
AminoTriComplex: Preclinical and Clinical Evidence for a Multi-Component Phytochemical Formulation Targeting Oxidative Stress, Mitochondrial Function, and Cancer-Related Pathways
2026 · Alexandre Tavartkiladze, Russel J Reiter, et al. · International Journal of Science and Research (IJSR)
PDF
Cisterna Chyli as an Evolutionary Incubator for Metastasis: Comparative Circulating Tumor Cell Phenotyping Across Cisterna Chyli, Peripheral Lymph and Blood in 614 Participants
2026 · Alexandre Tavartkiladze, Levan Tavartkiladze, et al. · Preprints.org
PDF
The Dysbiosis-Urolithin A-Melatonin Axis in Advanced Solid Tumors: A Pilot Observational Study and Proposal of a Composite Biomarker Triad
2025 · Alexandre Tavartkiladze, Russel J. Reiter, et al. · Preprints.org
PDF
Discrepant Dynamics of CA 19-9 and IL-6 in Colorectal Cancer: Mechanistic Rationale and a Practical Workup
2025 · Alexandre Tavartkiladze, Russel Reiter, et al. · Series of clinical and biomedical research.
Works count: 41
Citation count: 10
H-index: 2
I10-index:
Year
Topic
Type